Research funding means much more than just paying research projects to the Mukoviszidose e.V. It is the aim to raise awareness on Cystic Fibrosis and make CF-research attractive to scientists and research groups. Collaborations should be initiated in order to work together on the development of better treatments for cystic fibrosis disease and improve care.
The “Mukoviszidose Institut gemeinnützige Gesellschaft für Forschung und Therapieentwicklung mbH” (Cystic Fibrosis Institute - a non-profit limited company for therapeutic research and development (MI)), is a wholly-owned subsidiary of the Mukoviszidose e.V. (German cystic fibrosis association) in Bonn.
The MI was set up to support cystic fibrosis research, to network researchers, and to provide results from this research. Together, we work to strengthen research in the field of cystic fibrosis in order to improve treatment and make life easier with the disease.
The Cystic Fibrosis Institute gGmbH offers the following funding tools:
Aim: Answering a CF-relevant questions by supporting research projects
Young Scientists sponsorship
Aim: Financial support of young scientist to promote their scientific career in CF research with the goal, to focus them on CF research.
Academic visits and travel grants
Aim: Knowledge exchange, transfer of methods and discussion of scientific data with collaboration partners
National and international scientific events
Aim: Expert discussions on urging questions; international scientific exchange; presentation of scientific data
The evaluation process of applications is conducted through the Research Association for Cystic Fibrosis (Forschungsgemeinschaft Mukoviszidose, FGM).
Important: when applying please read the notes for applicants.
Project funding is restricted to Germany, but international collaborations are possible if the foreign partner applies for their own funding from another source, and not from the Mukoviszidose e.V..
The Mukoviszidose e. V. invites to submit new applications for small project grants.
The deadline for submission of applications is January, the 15th 2023.